Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pittsburgh, PA
NPI
1912084625
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
10922 Frankstown Rd
Pittsburgh, PA, 15235
Phone (412) 241-6111
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,782 services
Medicare patients, 2024
486
Average age 74
Drug cost, 2024
$4.0M
10,519 prescriptions
Company payments, 2025
$128K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vijay K Bahl was code 99213 (office e&m - established), 546 times for 307 patients. In total Vijay K Bahl billed 1,782 services in 23 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 546 | 307 | $60.89 | $33K |
| 99232 Hospital E&M - Subsequent | Facility | 339 | 82 | $59.47 | $20K |
| 99231 Hospital E&M - Subsequent | Facility | 309 | 107 | $37.39 | $12K |
| 83036 Blood Count | Office | 95 | 54 | $9.44 | $896 |
| 99442 Telephone Services | Office | 88 | 73 | $63.40 | $5,580 |
| 36415 Venipuncture Blood Collection | Office | 86 | 60 | $8.65 | $744 |
| 99223 Hospital E&M - Initial | Facility | 83 | 74 | $130.65 | $11K |
| 99222 Hospital E&M - Initial | Facility | 48 | 45 | $96.44 | $4,629 |
| 99233 Hospital E&M - Subsequent | Facility | 46 | 44 | $87.59 | $4,029 |
| 95251 Test - Miscellaneous | Office | 44 | 27 | $25.60 | $1,126 |
| 99203 Office E&M - New | Office | 35 | 35 | $80.12 | $2,804 |
| 90661 Vaccine Product | Office | 16 | 16 | $36.11 | $578 |
| G0008 Administration of influenza virus vaccine | Office | 13 | 13 | $30.77 | $400 |
| 99214 Office E&M - Established | Office | 12 | 12 | $88.46 | $1,062 |
By year: 2022 $106K for 2,001 services; 2023 $131K for 2,351 services; 2024 $99K for 1,782 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 95 | 54 | $9.44 | $896 |
| 36415 Venipuncture Blood Collection | 86 | 60 | $8.65 | $744 |
Medicare prescription drug claims, 2024
In 2024, the drug Vijay K Bahl prescribed most often to Medicare patients was Ozempic (Semaglutide), with 671 prescriptions and refills. In total Vijay K Bahl wrote 10,519 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 671 | 907 | 124 | $839K |
| Synthroid Levothyroxine Sodium | 576 | 1,402 | 148 | $54K |
| Levothyroxine Sodium Generic | 456 | 1,131 | 124 | $71K |
| Jardiance Empagliflozin | 383 | 699 | 82 | $390K |
| Metformin Hcl Er Metformin Hcl | 354 | 865 | 104 | $4,834 |
| Atorvastatin Calcium Generic | 343 | 934 | 94 | $4,367 |
| Unithroid Levothyroxine Sodium | 299 | 706 | 68 | $6,325 |
| Farxiga Dapagliflozin Propanediol | 292 | 474 | 62 | $256K |
| Mounjaro Tirzepatide | 285 | 349 | 52 | $353K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 246 | 592 | 94 | $25K |
| Metformin Hcl Generic | 243 | 604 | 66 | $2,737 |
| Trulicity Dulaglutide | 202 | 268 | 47 | $254K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 178 | 438 | 59 | $233K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 177 | 414 | 64 | $25K |
| Losartan Potassium Generic | 177 | 472 | 56 | $2,875 |
Brand drugs: 4,836 claims; generic drugs: 5,154 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vijay K Bahl $128K ($128K in general payments such as food, travel and fees) from 30 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $42K.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 45 | $42K |
| Ascendis Pharma Endocrinology Inc ASND | 21 | $25K |
| Lilly USA, LLC LLY | 49 | $23K |
| Novo Nordisk Inc NVO | 38 | $19K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 28 | $9,820 |
| Amgen Inc. AMGN | 18 | $6,315 |
| CeQur Corporation | 1 | $512 |
| Abbvie Inc. ABBV | 16 | $407 |
| Amneal Pharmaceuticals LLC AMRX | 14 | $240 |
| Dexcom, Inc. DXCM | 18 | $236 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.